Citation

86 FR 55619

Multiple canonical documents share this first-page citation.

Biomarkers and Surrogate Endpoints in Clinical Studies To Support Effectiveness of New Animal Drugs; Guidance for Industry; Availability Wednesday, October 6, 2021 86 FR 55619
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Withdrawal Wednesday, October 6, 2021 86 FR 55619